Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma
Pancreatic stellate cells (PSCs) mainly consist of cancer-associating fibroblasts in pancreatic ductal adenocarcinoma (PDAC). The receptor for advanced glycation end products (RAGE) is implicated in the pathophysiology of diabetic complications. Here, we studied the implication of RAGE in PSC activa...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17044c4b692544f5832864a0407f0f4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:17044c4b692544f5832864a0407f0f4f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:17044c4b692544f5832864a0407f0f4f2021-11-11T17:10:25ZDiabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma10.3390/ijms2221117161422-00671661-6596https://doaj.org/article/17044c4b692544f5832864a0407f0f4f2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11716https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Pancreatic stellate cells (PSCs) mainly consist of cancer-associating fibroblasts in pancreatic ductal adenocarcinoma (PDAC). The receptor for advanced glycation end products (RAGE) is implicated in the pathophysiology of diabetic complications. Here, we studied the implication of RAGE in PSC activation in PDAC. The activation of cultured mouse PSCs was evaluated by qPCR. The induction of epithelial mesenchymal transition (EMT) in PDAC cell lines was assessed under stimulation with culture supernatant from activated PSCs. A total of 155 surgically resected PDAC subjects (83 nondiabetic, 18 with ≦3-years and 54 with >3-years history of diabetes) were clinicopathologically evaluated. A high-fat diet increased the expression of activated markers in cultured PSCs, which was abrogated by RAGE deletion. Culture supernatant from activated PSCs facilitated EMT of PDAC cells with elevation of TGF−β and IL−6, but not from RAGE−deleted PSCs. Diabetic subjects complicated with metabolic syndrome, divided by cluster analysis, showed higher PSC activation and RAGE expression. In such groups, PDAC cells exhibited an EMT nature. The complication of metabolic syndrome with diabetes significantly worsened disease−free survival of PDAC subjects. Thus, RAGE in PSCs can be viewed as a new promoter and a future therapeutic target of PDAC in diabetic subjects with metabolic syndrome.Chiaki UchidaHiroki MizukamiYutaro HaraTakeshi SaitoSatoko UmetsuAkiko IgawaSho OsonoiKazuhiro KudohYasuhiko YamamotoHiroshi YamamotoSoroku YagihashiKenichi HakamadaMDPI AGarticletype 2 diabetesadvanced glycation end productspancreatic ductal adenocarcinomaRAGEEMTmetabolic syndromeBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11716, p 11716 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
type 2 diabetes advanced glycation end products pancreatic ductal adenocarcinoma RAGE EMT metabolic syndrome Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
type 2 diabetes advanced glycation end products pancreatic ductal adenocarcinoma RAGE EMT metabolic syndrome Biology (General) QH301-705.5 Chemistry QD1-999 Chiaki Uchida Hiroki Mizukami Yutaro Hara Takeshi Saito Satoko Umetsu Akiko Igawa Sho Osonoi Kazuhiro Kudoh Yasuhiko Yamamoto Hiroshi Yamamoto Soroku Yagihashi Kenichi Hakamada Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma |
description |
Pancreatic stellate cells (PSCs) mainly consist of cancer-associating fibroblasts in pancreatic ductal adenocarcinoma (PDAC). The receptor for advanced glycation end products (RAGE) is implicated in the pathophysiology of diabetic complications. Here, we studied the implication of RAGE in PSC activation in PDAC. The activation of cultured mouse PSCs was evaluated by qPCR. The induction of epithelial mesenchymal transition (EMT) in PDAC cell lines was assessed under stimulation with culture supernatant from activated PSCs. A total of 155 surgically resected PDAC subjects (83 nondiabetic, 18 with ≦3-years and 54 with >3-years history of diabetes) were clinicopathologically evaluated. A high-fat diet increased the expression of activated markers in cultured PSCs, which was abrogated by RAGE deletion. Culture supernatant from activated PSCs facilitated EMT of PDAC cells with elevation of TGF−β and IL−6, but not from RAGE−deleted PSCs. Diabetic subjects complicated with metabolic syndrome, divided by cluster analysis, showed higher PSC activation and RAGE expression. In such groups, PDAC cells exhibited an EMT nature. The complication of metabolic syndrome with diabetes significantly worsened disease−free survival of PDAC subjects. Thus, RAGE in PSCs can be viewed as a new promoter and a future therapeutic target of PDAC in diabetic subjects with metabolic syndrome. |
format |
article |
author |
Chiaki Uchida Hiroki Mizukami Yutaro Hara Takeshi Saito Satoko Umetsu Akiko Igawa Sho Osonoi Kazuhiro Kudoh Yasuhiko Yamamoto Hiroshi Yamamoto Soroku Yagihashi Kenichi Hakamada |
author_facet |
Chiaki Uchida Hiroki Mizukami Yutaro Hara Takeshi Saito Satoko Umetsu Akiko Igawa Sho Osonoi Kazuhiro Kudoh Yasuhiko Yamamoto Hiroshi Yamamoto Soroku Yagihashi Kenichi Hakamada |
author_sort |
Chiaki Uchida |
title |
Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma |
title_short |
Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma |
title_full |
Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma |
title_fullStr |
Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma |
title_full_unstemmed |
Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma |
title_sort |
diabetes in humans activates pancreatic stellate cells via rage in pancreatic ductal adenocarcinoma |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/17044c4b692544f5832864a0407f0f4f |
work_keys_str_mv |
AT chiakiuchida diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT hirokimizukami diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT yutarohara diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT takeshisaito diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT satokoumetsu diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT akikoigawa diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT shoosonoi diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT kazuhirokudoh diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT yasuhikoyamamoto diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT hiroshiyamamoto diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT sorokuyagihashi diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma AT kenichihakamada diabetesinhumansactivatespancreaticstellatecellsviarageinpancreaticductaladenocarcinoma |
_version_ |
1718432162413281280 |